Find Resources and Information

Bipolar Androgen Therapy: Cycling Testosterone Shocks Cancer Cells

Several years ago, medical oncologist Samuel Denmeade, M.D., Co-Director of the Johns Hopkins Prostate Cancer Program, and colleagues came up with a remarkable concept for attacking prostate cancer: alternating androgen deprivation therapy (ADT) with high-dose testosterone.

PCF Scientific Retreat 2021 Top Stories For Patients: Promising Treatments

Clinical Trials of New Therapies for Advanced Prostate Cancer

Highlights on Lutetium-PSMA from the American Society of Clinical Oncology 2022 Annual Meeting

Prostate cancer care declined during the COVID-19 pandemic

PRESTO Trial Aims to Help Guide Treatment for Patients with Rising PSA After Surgery

Researchers Identify a New Subtype of Advanced Prostate Cancer

U.S. FDA Approves Blue Earth Diagnostics’ POSLUMA®

TikTok Famous Goat Farmer Stays Strong Through Prostate Cancer, Heart Problems and Anxiety

10 tips that helped me respond to a prostate cancer diagnosis

SEA Blue Prostate Cancer Walk/Run Raises Funds, Awareness

Targeted ‘radioligand’ improves survival in advanced prostate cancer

Research Suggests How Tumors Evolve to Become Aggressive Form of Prostate Cancer

Study identifies prostate cancer subgroup likely to benefit from adjuvant radiotherapy

New Therapy for Aggressive Prostate Cancer Improves Survival

‘Friends’ actor James Michael Tyler, who played Gunther, shares prostate cancer diagnosis

Diagnosed with prostate cancer at 37, man shares story to erase stigma

‘We’re Not Gonna Take It’—Bayer and Twisted Sister rocker join nonprofit to push back on prostate cance

Bone-Protecting Agents Reduce Fracture Risk During Prostate Cancer Treatment

A Chat With: Former Philadelphia Mayor Michael Nutter